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ABSTRACT Adherence to preventive asthma treatment is poor, particularly in children, yet the factors
associated with adherence in this age group are not well understood.
Adherence was monitored electronically over 6 months in school-aged children who attended a regional
emergency department in New Zealand for an asthma exacerbation and were prescribed twice-daily inhaled
corticosteroids. Participants completed questionnaires including assessment of family demographics,
asthma responsibility and learning style. Multivariable analysis of factors associated with adherence was
conducted.
101 children (mean (range) age 8.9 (6–15) years, 51% male) participated. Median (interquartile range)
preventer adherence was 30% (17–48%) of prescribed. Four explanatory factors were identified: female sex
(+12% adherence), Asian ethnicity (+19% adherence), living in a smaller household (−3.0% adherence per
person in the household), and younger age at diagnosis (+2.7% for every younger year of diagnosis) (all p<0.02).
In school-aged children attending the emergency department for asthma, males and non-Asian ethnic
groups were at high risk for poor inhaled corticosteroid adherence and may benefit most from
intervention. Four factors explained a small proportion of adherence behaviour indicating the difficulty in
identifying adherence barriers. Further research is recommended in other similar populations.
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Introduction
Asthma is one of the most common chronic conditions in childhood [1]. Adherence with preventive
medication remains poor in this age group (⩽16 years of age) [2, 3]. Poor adherence with inhaled
corticosteroids is associated with morbidity [4] and mortality [5]. Interventions to improve adherence have
shown benefits on adherence; however, effects are inconsistent, even when using similar strategies [6]. In order
to develop effective childhood interventions it is important to investigate the unique adherence barriers
children face [7], as these are different to adults [4, 7]. There are few studies in children that aim to understand
these barriers, and even fewer interventional studies which aim to improve adherence in children [6, 8].
Previous research investigating adherence barriers in childhood have used inconsistent methodology, with data
on adherence factors being collected from either the child, a proxy (e.g. parent) or both. Commonly used
adherence measures, such as self-reported or pharmacy claims data, are subject to bias [3, 9]. Electronic
monitoring provides the most objective measure of adherence monitoring [3, 8]; however, only a few studies
have used electronic monitoring to provide adherence data to investigate adherence barriers [4, 10–13]. Of the
studies that have used electronic monitoring, these have tended to focus on a narrow set of adherence barriers,
such as psychological factors [4, 10, 12] or asthma knowledge [11], or used data collected over only a short
duration [13]. MORTON et al. [3] recently reviewed the literature surrounding adherence in childhood asthma.
The authors reported a paucity of studies investigating adherence barriers in children, and that future
studies investigating adherence in children with asthma should use electronically monitored adherence data.
Therefore, there is a need to examine a range of adherence barriers unique to children using objective
adherence data.
Learning style is one adherence factor that has not been previously examined. Learning style has been
linked with a patient’s understanding of health information and subsequent medication taking behaviours
[14] and responses to interventions [15]. Although there is no current literature examining this relationship,
learning style may influence adherence. For example, individuals with an aural learning style may benefit
more from an auditory intervention such as reminders, than those with alternative learning styles.
We previously conducted a randomised controlled trial investigating the effects of audio-visual reminders
on medication adherence and asthma outcomes in children with asthma [16]. The present study uses the
objectively measured adherence data from the randomised controlled trial to: 1) identify the adherence
barriers unique to children, particularly in those at high risk of non-adherence; and 2) examine the relative
importance of these factors for non-adherence, including the novel concept of learning style as a factor
associated with adherence.
Material and methods
Study subjects and design
The randomised controlled trial investigated the effect of a reminder on adherence to preventer treatment
and asthma outcomes, as described previously [16]. Briefly, 220 children between 6 and 15 years of age
were recruited from the regional emergency department in Auckland, New Zealand. Inclusion criteria
were: current diagnosis of asthma; current treatment or those started on treatment at the emergency
department with a twice-daily inhaled corticosteroid; no comorbid congenital heart disease, chronic lung
disease (other than asthma) or a severe chronic medical condition leading to increased morbidity; and
residence inside the Auckland area.
Patients were enrolled after a minimum of 4 weeks had elapsed since hospital attendance, and were
followed prospectively for 6 months, with 2-monthly follow-up visits by study investigators. Patients were
randomly allocated to the intervention (n=110) or control (n=110) group. All received an electronic
monitoring device for use with their preventer inhaler. The intervention group had the reminder function
enabled; this was disabled in the control group. Information on asthma control was collected at each visit
and at the end of the study participants and their caregiver completed a series of questionnaires to assess
variables associated with adherence. Verbal and written informed consent was obtained from the child’s
parent or caregiver, and ethics approval was received from the New Zealand Northern Y Regional Ethics
Committee (NTY/08/12/116) and District Health Boards. The trial was registered with the Australian
New Zealand Clinical Trials Registry, number ACTRN12613001353785.
Adherence measurement
Inhaled corticosteroid adherence was objectively measured by an electronic monitoring device (Smart
Track; Nexus 6 Ltd, Auckland, New Zealand), which recorded date, time and number of doses taken. An
on-board screen displayed the date and time of the last dose. Participants were unaware of the device
adherence monitoring function. This covert monitoring method followed published ethical guidelines as
discussed previously by RAND and SEVICK [17], and was accordingly approved by the regional ethics
committee. At the end of the study, participants and their general practitioner, or other asthma healthcare
ERJ Open Res 2016; 2: 00087-2015 | DOI: 10.1183/23120541.00087-2015 2
ASTHMA | A.H.Y. CHAN ET AL.
provider, were offered access to the study results. Adherence was defined as median percentage of the daily
prescribed dose taken.
Analysis of factors associated with adherence
Caregivers (parent or guardian) of participants completed self-reported questions on demographics and the
primary caregiver’s highest educational qualification (none (did not finish secondary school), secondary,
tertiary or postgraduate). Participant ethnicity was obtained from their New Zealand National Health Index
number. Deprivation was assessed using the NZDep2006 Deprivation Index (1=least deprived, 10=most
deprived area) of the area the participant lived in [18]. Caregivers self-reported household size (number of
people usually living in the household) and family status (single/divorced/separated/widowed/married/de
facto (cohabitating)/extended family or whanau (Māori concept of an extended family or community of
families living together)). Information on the caregivers’ experience of the health system and healthcare
access was collected using the following questions (scored yes/no): “Do you feel you can discuss concerns
with the health professional who looks after the child’s asthma?”; “Have you ever delayed or avoided
picking up medications due to cost?”; “Have you ever delayed or avoided seeing the doctor due to cost?; “Is
your doctor easy to access?” and “Is your local pharmacy easy to access?”.
Age at diagnosis was obtained by caregiver self-report. Asthma control was measured using two validated
questionnaires: the childhood Asthma Control Test (0=worst control, 27=best control) [19] completed by
the child and caregiver, and the Asthma Morbidity Score [20] (17=maximal morbidity, 4=lowest
morbidity) completed by the caregiver. Caregivers answered a question about side-effects (scored yes/no):
“Does the child complain of, or have, any side-effects from their medications?”. Caregivers gave
information about the type of healthcare professional who followed up their child's asthma (in addition to
the 2-monthly investigator-initiated visits), by choosing one or more of the following options: asthma
nurse, specialist, general physician (family doctor), no usual care follow-up or other. Asthma responsibility
was evaluated using the 10-item Asthma Responsibility Questionnaire [21] completed by the caregiver.
This assesses how responsibility is shared for 10 asthma management tasks. Each item is scored from 1
(parent is completely responsible) to 5 (child is completely responsible); total score 10=maximum parent
responsibility, 50=maximum child responsibility. The child’s asthma knowledge was assessed using the
child-reported 24-item questionnaire (0=worst knowledge, 26=best knowledge) validated for primary
school-aged children [22].
Children completed the Visual Aural Read/Write Kinaesthetic (VARK) Learning Styles Inventory for
Younger People [23], which identified each participant’s learning style preference (visual, aural, reading/
writing and kinaesthetic, or various combinations of these) based on the standard scoring system [24]. As
this questionnaire was for children aged ⩾12 years, the language was modified for the reading skills of our
population of 6–15 year olds. Results were categorised into two groups for analysis: those with an aural
learning style preference (aural group) versus no aural learning style preference (non-aural group).
Statistical analysis
Descriptive statistics were used to describe the study population. All statistical tests were performed at the
0.05 level of significance (two-tailed) using SPSS Statistics (version 22; IBM, Armonk, NY, USA) or SAS
(version 9.3; SAS Institute, Cary, NC, USA).
Factors associated with adherence
Unadjusted analysis
To avoid interference from the intervention, only data from the control group of the trial was used as the
analytical cohort to analyse factors associated with adherence. Unadjusted analyses on 20 variables were
conducted in this analytical cohort using a general linear model.
All possible subsets regression
To determine the factors associated with adherence, an all possible subsets regression was conducted. This
multivariable regression technique was chosen over the traditional stepwise regression as it tests all
possible subsets of potential variables. This allows models that have similar predictive value to be
identified and compared, rather than selecting just one model. Binary variables with low numbers in one
outcome group, i.e. <25% of participants in one outcome group, were not included in the multivariable
regression. Participants with complete data across all remaining variables were used for the multivariable
analysis. The remaining variables were included in the model and multiple subsets of variables were
generated, ranging from single variable models to models using all remaining variables. By examining the
five best models at each level, alternative variable combinations were assessed, including whether the
addition of other variables to the model led to a masking effect. The model accounting for the greatest
variance (maximum R2), whilst still consisting of only significant (p<0.05) variables, was selected.
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TABLE 1 Characteristics of 101# participants in the analytical cohort and unadjusted analyses of 20 factors associated with
adherence
Variable Participants Effect size p-value
Age years 8.9±2.7 −1.5% (95% CI−3.2–0.2%) per year 0.09
Sex
Male 52 26 (15–43) 0.05
Female 49 40 (19–60)
Qualification of primary caregiver
None 8 36 (11–42)
Secondary school 22 28 (15–53) 0.81
Tertiary 45 26 (12–47)
Postgraduate 22 42 (21–51)
Missing 4
Ethnicity
Māori 10 19 (13–44)
European 39 26 (17–43)
Pacific Peoples 20 28 (13–40) 0.002
Middle Eastern/Latin American/African 4 35 (5–68)
Asian 19 47 (30–83)
Other 9 31 (21–46)
Deprivation index¶ 6.0±2.7 +0.002% (95% CI−1.7–1.7%)
per deprivation scale
0.99
People in household 4.8±1.9; 98# −3.4% (95% CI−5.8–−0.1%)
per person added to household
0.005
Family status
Single+ 35 26 (15–47) 0.39
Not single§ 65 32 (18–49)
Missing 1
Able to discuss concerns with the healthcare
professional looking after the child
No 8 24 (6–49) 0.68
Yes 92 31 (17–48) 0.68
Missing 1
Delayed picking up medications due to cost
No 78 31 (16–48)
Yes 21 26 (16–49) 0.87
Missing 2
Delayed seeing the doctor due to cost
No 69 31 (16–54)
Yes 30 28 (16–46) 0.28
Missing 2
Easy access to doctor
No 10 37 (18–52) 0.91
Yes 90 30 (17–48) 0.91
Missing 1
Easy access to pharmacy
No 2 20 (7– -) 0.37
Yes 99 30 (17–48)
Age at asthma diagnosis years 3.3±2.3 −1.7% (95% CI−3.7–0.3%) per year 0.09
Childhood Asthma Control Test 18.8±4.2; 100# +0.9% (95% CI−0.2–2.0%) per 1 point
on the Childhood Asthma Control Test
0.11
Asthma Morbidity Score 9.2±2.6; 100# −0.3% (95% CI−2.1–1.5%) per 1 point
on the Asthma Morbidity Score
0.73
Medication side-effects
No 91 29 (17–48) 0.84
Yes 10 33 (11–46)
Healthcare provider involved in routine
follow-up asthma care
None (no follow-up) 2 72 (60– -)
General practitioner 74 26 (12–43) 0.003
Specialist 5 31 (23–61)
Asthma nurse 15 51 (15–85)
Multiple providers 5 46 (26–61)
Continued
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Data were then analysed using an alternative model as a sensitivity analysis by performing the all subsets
regression with the variables that had missing data removed (rather than removal of participants with
missing data).
Effect of aural learning styles
Analysis of the effect of aural learning styles on adherence was conducted using a general linear model.
Data from both the intervention and control groups were used as participants with an aural learning style
may not only be more responsive to an auditory adherence intervention, but may also be more responsive
to adherence advice from health providers, which is often delivered verbally.
Results
Of the 110 participants forming the analytical cohort, nine did not complete the questionnaires, leaving
101 for analysis. Overall adherence was low (median (interquartile range) adherence 30% (17–48%)).
Table 1 shows the characteristics of the analytical cohort (n=101) and describes the unadjusted analyses of
factors associated with adherence.
Unadjusted analyses of factors associated with adherence
Only three out of 20 variables examined were significantly associated with adherence to preventive treatment
(table 1). These were ethnicity (Asian ethnicity most adherent), living with a lower number of people in the
household, and type of healthcare provider involved in asthma follow-up (those with no asthma follow-up by
their own healthcare provider had better adherence, though the outcome group only had two participants).
Younger age, female sex and a younger age at diagnosis were of borderline significance.
Multivariable analysis of factors associated with adherence
The following variables, which had very low numbers in one outcome group compared to the other, were
not included in the analysis: whether or not the caregiver could discuss concerns with their asthma
healthcare provider; whether or not the caregiver had ever delayed picking up medicines due to cost;
whether or not the caregiver had easy access to the doctor or pharmacy; presence or absence of medication
adverse effects in the child; and lack of follow-up for the child’s asthma by their own healthcare provider.
After removal of these variables, 87 of the 101 participants in the analytical cohort had complete data
across all variables and were included in the multivariable analysis.
The all subsets regression selected a subset of four factors that together explained 30% of the variance in
objective adherence (R2=0.33; adjusted R2=0.30) (table 2). The addition of all the other predictor variables
only accounted for an additional 14% in variance (R2=0.47; adjusted R2=0.29) and included variables that
were not statistically significant. The multivariable analysis found those of Asian ethnicity, female sex,
living with a lower number of people in the household and having a younger age at diagnosis were more
likely to adhere to treatment. Lack of asthma follow-up by their own healthcare provider was also
significant, but as there were only two participants who did not have follow-up this was not included in
the model (median adherence 72%) (table 1). These two participants had high adherence. There was no
TABLE 1 Continued
Variable Participants Effect size p-value
Asthma Responsibility Questionnaire 23.7±8.1 −0.2% (95% CI−0.7–0.4%) per 1 point
of Asthma Responsibility Questionnaire
0.53
Asthma Knowledge Test 19.1±2.7 +0.7% (95% CI−1.0–2.4%) per 1 point
of Asthma Knowledge Test
0.42
Learning styles
Aural 64 29 (17–48) 0.76
Non-aural 30 30 (14–49)
Missing 7
Data are presented as mean±SD, n or median (interquartile range), unless otherwise stated. Bold data indicates statistical significance. #: data
do not total 101 for some parameters due to missing data from participants who did not completed the relevant questionnaire(s). Median
(interquartile range) adherence for the total sample (n=101) was 30% (17–48%); ¶: based on the NZDep2006 deprivation index (1=least
deprived, 10=most deprived). This is an indicator of socioeconomic deprivation of the area where the individual resides. Scores are derived
from census data on income, home ownership, employment, qualifications, family structure, housing, access to transport and
communications; +: single parent/divorced/separated /widowed/single; §: de facto/extended whanau/married.
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indication that any variables were masked by the presence of other variables. The sensitivity analysis
produced very similar results confirming the results of the all subsets regression described above.
Effect of aural learning styles
There was no relationship between aural learning style and adherence in either the control (analytical
cohort for this study) or in the intervention (reminder) group (aural 29% versus non-aural 30% (p=0.76)
and aural 85% versus non-aural 88% (p=0.34), respectively).
Discussion
This study investigated factors associated with adherence in children presenting to a regional emergency
department with an asthma exacerbation. Electronically monitored adherence was poor with median
adherence being 30%, a rate similar to other studies in children at high risk of non-adherence [25–27] but
lower than the average reported adherence from studies using electronic monitoring and when compared
to other developed Western countries [3, 8]. We examined a number of factors that have previously been
associated with adherence, such as ethnicity [13, 28] and asthma knowledge [10], as well as factors not
previously investigated, such as learning style. Of the variables examined in this study, only a few were
significantly associated with adherence.
Ethnicity had a strong association with adherence, with Asian participants having the highest overall
adherence (47%). The reason for this is unclear. There is little literature available on adherence for ethnic
groups in New Zealand beyond Māori, Pacific and European populations. Education studies in Australia show
that Asian students are more compliant with orders from teachers than other ethnic groups [29] due to
respect and perceived dominance of the teacher [30]. The healthcare provider–patient relationship may be
associated with a similar respectful or submissive response, which may enhance adherence. Māori children
had the poorest adherence (median adherence 19%), followed closely by New Zealand European (26%) and
Pacific peoples (28%). From studies in mild-to-moderate asthmatics, Māori and Pacific children show poorer
asthma control than other ethnic groups [31] due to under treatment and poor adherence with preventive
treatment [31, 32]. Therefore, the ethnic differences in our study were unexpected, as although adherence rates
for New Zealand Europeans were higher than Māori children, they were lower than that of other minority
ethnic groups. The participants in our study attended the emergency department for asthma and therefore
represent those with the poorest asthma control and adherence [27]. This suggests that the effect of ethnicity
may be different in those with poorly controlled asthma and at high risk of non-adherence, but more research
is needed to confirm this. We note that the adherence rate in our population of high-risk children was
particularly low when compared to populations recruited from outpatient clinics [12, 33–37], and more
similar to those recruited from tertiary centres or hospitals [38]. Indeed, in adults, KRISHNAN et al. [39]
reported a drop in inhaled corticosteroid use to ∼50% within a week of hospital discharge after an asthma
exacerbation. This highlights the potential vulnerability of patients presenting to tertiary care settings and the
importance of considering the contribution of this as a potential marker of poor adherence. The high-risk
nature of a population presenting to the emergency department with asthma may override the usual effects of
other adherence determinants, such as ethnicity, as seen in our study.
Female sex was significantly associated with better adherence in our study. The relationship between sex and
adherence is inconsistent in the literature, with many studies showing no association [9, 40, 41]. Only one
study has reported an association between female sex and higher adherence in adult asthma [42]. In other
chronic conditions, female sex has been linked with poorer adherence in adolescents [43]. Mental health and
coping strategies may mediate the relationship between sex and adherence [43], but we did not measure
psychological factors.
No clear relationship was found between socioeconomic status, determined by NZDep scores, and
adherence. Some studies have reported a lack of correlation between adherence and general socioeconomic
status, family income or qualifications of the primary caregiver [35, 44], although others report low
TABLE 2 Multivariable regression analysis with objective adherence as independent variable#
Variable Effect size p-value
Sex 12±4% 0.005
Asian ethnicity 19±5% <0.001
People in the household −3.0±1.0% per person 0.01
Age at asthma diagnosis years −2.7±0.9% per year 0.004
Data are presented as change±SE. #: n=87.
ERJ Open Res 2016; 2: 00087-2015 | DOI: 10.1183/23120541.00087-2015 6
ASTHMA | A.H.Y. CHAN ET AL.
adherence rates in those with poor socioeconomic status [3]. Compared to studies that report higher
overall adherence, the population in our study did incline towards higher deprivation scores (mean
deprivation 6 out of 10). We found a significant relationship between household size and adherence, a
factor seldom studied in asthma. KYNGÄS [45] found that adherence improved with increasing number of
siblings and similarly LIEU et al. [46] reported better adherence in larger families. Our study found the
opposite effect, with larger household size associated with poorer adherence. It is possible that larger
families present more competing demands, thus limiting the time available to manage a child’s asthma
[47] and increasing forgetfulness, a key reason for non-adherence in childhood asthma [48]. This negative
effect of family size on adherence may be more pronounced in our study as over half of the participants
were aged <8 years of age. Previous studies have demonstrated that younger children have the majority of
their medications managed by their parents [4, 47, 49], which may contribute to poorer adherence with
increased household size. This is also supported by the negative relationship seen between asthma
responsibility scores and adherence, where adherence decreased with increasing child responsibility for
their own asthma management, though the relationship did not reach statistical significance.
The relationship between age at diagnosis and adherence is unclear; the few studies investigating this
relationship have not found any association [40, 41]. Our study found age at diagnosis was a significant
factor, with a reduction in adherence of 3% per increasing year of age at diagnosis. There was a
corresponding nonsignificant trend between age of the child and adherence, with adherence being worse
in older children, similar to previous findings [2, 4, 44, 45, 50]. This may, in part, explain the association
between age of diagnosis and adherence. The association between increased age and worsened adherence
might also explain the overall low adherence seen in this population. Most previous studies that have
reported higher adherence have included much younger age range, from as young as 15 months [3].
Disease duration may play a role as those with a younger age of onset have more opportunity for habit
formation for medication adherence [51]. Conditioning may lead children or their parents to believe that
asthma is a long-term condition requiring long-term preventive treatment and, as a result, lead to better
adherence. Indeed, adherence is higher in those that believe asthma is a long-lasting condition [42].
This is the first study investigating the impact of learning style on adherence. A link between the two is
plausible given that learning style is associated with behaviour [14, 15], but no association was found in
either the group receiving the auditory intervention or control. This may be due to the difficulties in
characterising learning styles in children as younger children tend to have multimodal learning styles
rather than a single learning modality [23]. The lack of a validated tool for assessing learning style in the
younger age groups in our study may have also limited the accuracy of determining the child’s learning
style. Although a relationship between learning styles and adherence was not found, there is a possibility
that interventions tailored to an individual’s learning style may be more successful. The literature supports
interventions that are personalised to an individual [3, 8]; future research should investigate the usefulness
of incorporating learning style into the intervention tailoring process.
Of the factors that were investigated, only four were found to be significantly associated with adherence.
However, these factors still only explained 30% of the variance seen in adherence. Although a wide range of
adherence determinants were examined, we did not investigate the effect of illness perceptions [52–57] or
medication beliefs [12, 50, 58–62], which are thought to be more powerful determinants of adherence [57] than
sociodemographic and clinical factors in adults. In children, the review by DROTAR and BONNER [63] of studies
investigating the factors associated with adherence in children reports that parental and, to a lesser extent, child
beliefs demonstrate significant relationships with adherence. Medication beliefs and illness perceptions were not
measured in our study but future research should include them in order to develop a clearer understanding of
the extent to which these may explain adherence behaviour in children with poorly controlled asthma and to
investigate how these may interact with the adherence determinants identified in our study.
The generalisability of our study results may be limited by data collection in a single centre and country.
Nevertheless, our study population were representative of the total population presenting to the emergency
department with asthma, as described previously [16], and included a wide range of ethnic and
socioeconomic groups. Due to missing data we excluded 14 participants from the multivariable analysis,
which could have led to selection bias. However, bias as a result of this exclusion is unlikely as our
sensitivity analysis, where variables with missing data were excluded rather than participants, showed
similar results. Questionnaires were administered in the presence of research personnel, which may have
affected the reliability of the data collected. A small number of participants chose not to complete some
questions, but the numbers with missing data were low and unlikely to affect our results. The application
of these findings to the design of adherence interventions may be limited, as the adherence determinants
identified were largely non-modifiable. Nevertheless, our findings add important information to the
literature on factors that contribute to poor adherence in children, particularly in those with poorly
controlled asthma. As the factors identified from our study are easily quantifiable, they may be used to
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help prioritise those at greatest need for intervention. Our work sets a platform for further research into
how potentially modifiable adherence determinants, such as medication beliefs, may be related to
non-modifiable factors such as ethnicity or duration/experience in managing asthma, and how these
non-modifiable factors may serve as proxies for identifying those who are most at risk of poor adherence.
In summary, female sex, Asian ethnicity, smaller household size and younger age at diagnosis were strongly
associated with better preventive medication adherence in children with poorly controlled asthma presenting
to a regional emergency department. These factors explained only 30% of the variation in adherence,
highlighting the difficulty of identifying adherence barriers in this age group. There was no association
between adherence and learning styles. Further research in other emergency department populations is
needed. Given the combination of poor adherence and high risk for life-threatening asthma in children
presenting to the emergency department, there is an urgent need to identify the specific adherence barriers
and develop effective interventions for this population of children.
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